## LRCX: Lam Research Corporation - XLK: Technology

### Executive Summary

No thesis match: MRS_10 1.6% below STRENGTH zone (3.0-6.0%); PEG 2.39 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($141.13)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 4, Bearish: 0)

**1. Panagora Asset Management Inc. Acquires 11,461 Shares of Lam Research Corporation $LRCX**
- Source: MarketBeat | 20251201T125211 | Bullish | Relevance: 99%
- Panagora Asset Management Inc. increased its stake in Lam Research Corporation by 1.4% in Q2, acquiring 11,461 shares to reach a total of 832,578 shares worth approximately $81.0 million. Other major institutional investors like Norges Bank and Vanguard also made significant moves, with institutions collectively owning about 84.61% of the semiconductor company's stock. Analysts currently hold a "Moderate Buy" consensus rating for Lam Research with a target price of $152.17, following a positive Q1 EPS beat and strong revenue growth.

**2. Lam Research Corporation $LRCX Shares Sold by Elevation Point Wealth Partners LLC**
- Source: MarketBeat | 20251201T094310 | Neutral | Relevance: 98%
- Elevation Point Wealth Partners LLC significantly reduced its stake in Lam Research Corporation ($LRCX) by 96.3% during the second quarter. Despite this, other institutional investors have acquired new positions in LRCX shares. The article also details Lam Research's recent financial performance, upcoming dividend, analyst ratings, and insider trading activities.

**3. Lam Research Corp. stock outperforms competitors on strong trading day**
- Source: MSN | 20251129T152144 | Bullish | Relevance: 98%
- Lam Research Corp. (LRCX) stock rose on Monday, outperforming its competitors. The stock closed at $1,059.08, marking an increase of 0.65% from the previous trading day, while the S&P 500 fell 0.31%. This performance led to mixed results compared to its rivals over the past year.

**4. Northwestern Mutual Wealth Management Co. Buys 59,477 Shares of Lam Research Corporation $LRCX**
- Source: MarketBeat | 20251129T115310 | Somewhat-Bullish | Relevance: 98%
- Northwestern Mutual Wealth Management Co. increased its stake in Lam Research Corporation by 8.7% during the second quarter, acquiring an additional 59,477 shares and now owning 740,049 shares valued at $72.04 million. The article details recent financial performance, including the company's Q3 revenue and EPS surpassing analyst expectations, and future guidance. It also covers recent analyst ratings, insider trading activities, and dividend information for Lam Research.

**5. Lam Research Corporation $LRCX Shares Acquired by MBM Wealth Consultants LLC**
- Source: MarketBeat | 20251201T125831 | Bullish | Relevance: 98%
- MBM Wealth Consultants LLC significantly increased its stake in Lam Research Corporation (NASDAQ:LRCX) by 25.9% in Q2, acquiring an additional 4,088 shares and now owning 19,877 shares valued at $1.935 million. Despite this institutional buying, company insiders have been net sellers, with significant sales by Director Bethany Mayer and SVP Vahid Vahedi totaling $14.9 million in the last three months. Lam Research recently beat quarterly earnings estimates and provided optimistic Q2 FY2026 guidance, alongside declaring a quarterly dividend of $0.26 per share.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 3, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-02 | Morgan Stanley | $158 | $137 | +15% |
| 2025-11-25 | UBS | $175 | $165 | +6% |
| 2025-11-12 | Citigroup | $190 | $175 | +9% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-02 | Morgan Stanley | main | Equal-Weight |
| 2025-11-25 | UBS | main | Buy |
| 2025-11-12 | Citigroup | main | Buy |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 11 ($0.00M) |
| Sells | 6 ($14.07M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 39.7% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 6 / 3 |

**Top Holders:**
- Vanguard Group Inc: 10.4% (+0.3%)
- Blackrock Inc.: 9.9% (+1.7%)
- JPMORGAN CHASE & CO: 4.8% (+47.4%)
- State Street Corpora: 4.8% (+0.4%)
- Geode Capital Manage: 2.7% (-0.5%)

### Key Risks

1. Heavy insider selling: $14M sold (6 transactions in 90 days).
2. Market regime shift could impact high-beta names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- Analyst target momentum: 3 raises (avg +10%) could attract flows.
- Momentum building: MRS_10 improving +1.4% over 5 days suggests accumulation.

### Fundamentals

PEG ratio 2.39 elevated, pricing in significant growth expectations. Quality metrics strong (ROE 62%, ROA 20%, margin 30%). Balance sheet: strong liquidity (2.2x), $1.6B free cash flow. Analyst sentiment positive (3 raises, avg +10%). Insider selling cluster ($14.1M in 90 days), potential headwind. Institutional flow bullish (6 buying vs 3 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $212.2B |
| Beta | 1.78 |
| 52W Range | $56.32 - $169.69 |
| Short Interest | 2.9% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 2.39 |
| Forward P/E | 27.7 |
| Current P/E | 32.1 |
| YoY Growth | 15.8% |
| EPS Direction | RISING |

### Technicals

MRS_10 strengthening from 0.2% to 1.6% (+1.4% in 5 days), confirming momentum buildup. Below STRENGTH zone by 1.4pp (needs >3.0% for momentum thesis). MRS_5 at 0.1% confirms short-term momentum alignment. Full SMA alignment bullish (above 20/50/200 SMAs). RSI neutral at 54.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | 1.58% (CS: 78) | Neutral |
| RSI_14 | 54.1 | Neutral |
| MACD Histogram | -0.33 | Bearish |
| vs SMA20 | 1.004x | Above |
| vs SMA50 | 1.051x | Above |
| vs SMA200 | 1.505x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $154.79
- **Stop Loss:** $141.13 (8.8% risk)
- **Target:** $168.45 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 87
- **Position Value:** $13,466.73
- **Portfolio %:** 13.47%
- **Risk Dollars:** $1,200.00
- **Risk Per Trade:** 1.20%
- **Modifiers:** L1 100% | L2 120% | Combined 1.20x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | IGNITION (Zone D) | 1.20x |

### Earnings

**Next:** 2026-01-28 (Est: $1.16)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $1.22 | $1.26 | +3.3% |
| 2025Q2 | $1.21 | $1.33 | +10.4% |
| 2025Q1 | $1.00 | $1.04 | +4.1% |
| 2024Q4 | $0.88 | $0.91 | +3.5% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_10*